Analystreport

West Pharmaceutical Services, Inc. (NYSE: WST) had its price target lowered by analysts at KeyCorp from $400.00 to $350.00. They now have an "overweight" rating on the stock.

West Pharmaceutical Services, Inc.  (WST) 
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am Check Earnings Report
US:NYSE Investor Relations: investor.westpharma.com